Martha Potts Fishman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 8 | 2024 | 939 | 1.120 |
Why?
|
| Hemoptysis | 1 | 2019 | 150 | 0.600 |
Why?
|
| Lung Diseases | 4 | 2023 | 1940 | 0.570 |
Why?
|
| Hemorrhage | 1 | 2018 | 3461 | 0.260 |
Why?
|
| Heart Defects, Congenital | 2 | 2024 | 4697 | 0.260 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2024 | 131 | 0.220 |
Why?
|
| STAT5 Transcription Factor | 1 | 2022 | 269 | 0.190 |
Why?
|
| Endocrine System | 1 | 2002 | 111 | 0.180 |
Why?
|
| Infant | 10 | 2024 | 36386 | 0.180 |
Why?
|
| Pharmaceutical Services | 1 | 2022 | 145 | 0.170 |
Why?
|
| Pleural Diseases | 1 | 2021 | 138 | 0.170 |
Why?
|
| Respiratory Function Tests | 1 | 2024 | 1693 | 0.160 |
Why?
|
| Retroviridae | 1 | 2002 | 847 | 0.160 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 334 | 0.160 |
Why?
|
| Eosinophilia | 1 | 2023 | 556 | 0.150 |
Why?
|
| Bronchoscopy | 1 | 2024 | 909 | 0.150 |
Why?
|
| GTPase-Activating Proteins | 1 | 2021 | 465 | 0.150 |
Why?
|
| Bronchiectasis | 1 | 2019 | 141 | 0.150 |
Why?
|
| Pneumothorax | 1 | 2021 | 392 | 0.140 |
Why?
|
| Child, Preschool | 9 | 2024 | 42500 | 0.140 |
Why?
|
| Lung | 4 | 2024 | 10033 | 0.130 |
Why?
|
| Recurrence | 2 | 2019 | 8501 | 0.130 |
Why?
|
| Islets of Langerhans | 1 | 2002 | 1349 | 0.120 |
Why?
|
| Pancreas | 1 | 2002 | 1700 | 0.120 |
Why?
|
| Biopsy | 2 | 2024 | 6763 | 0.120 |
Why?
|
| Rare Diseases | 1 | 2020 | 635 | 0.120 |
Why?
|
| Child | 12 | 2024 | 80564 | 0.120 |
Why?
|
| Pulmonary Medicine | 1 | 2016 | 222 | 0.110 |
Why?
|
| Biological Products | 1 | 2023 | 942 | 0.110 |
Why?
|
| Cystic Fibrosis | 1 | 2022 | 1287 | 0.100 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2014 | 239 | 0.100 |
Why?
|
| Infant, Newborn | 5 | 2019 | 26346 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 568 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 2900 | 0.090 |
Why?
|
| Retrospective Studies | 8 | 2024 | 81514 | 0.080 |
Why?
|
| Radiography, Thoracic | 2 | 2016 | 1315 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2019 | 9649 | 0.070 |
Why?
|
| Registries | 1 | 2023 | 8297 | 0.070 |
Why?
|
| Boston | 1 | 2019 | 9338 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2019 | 2821 | 0.070 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2009 | 452 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2741 | 0.060 |
Why?
|
| Logistic Models | 1 | 2019 | 13266 | 0.060 |
Why?
|
| Homozygote | 2 | 2021 | 1775 | 0.050 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2024 | 124 | 0.050 |
Why?
|
| Humans | 17 | 2024 | 765968 | 0.050 |
Why?
|
| Male | 11 | 2024 | 363698 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 310 | 0.050 |
Why?
|
| Pediatrics | 1 | 2016 | 3606 | 0.050 |
Why?
|
| Hypertension | 1 | 2021 | 8626 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39193 | 0.050 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2021 | 38 | 0.050 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2021 | 86 | 0.040 |
Why?
|
| Risk Factors | 4 | 2024 | 74840 | 0.040 |
Why?
|
| Lymphocytosis | 1 | 2021 | 120 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 20659 | 0.040 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 234 | 0.040 |
Why?
|
| Female | 10 | 2024 | 396112 | 0.040 |
Why?
|
| Foundations | 1 | 2020 | 95 | 0.040 |
Why?
|
| Leukocytosis | 1 | 2021 | 248 | 0.040 |
Why?
|
| Adolescent | 4 | 2024 | 88835 | 0.040 |
Why?
|
| Neuroendocrine Cells | 1 | 2020 | 61 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2023 | 1243 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7425 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2002 | 854 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2009 | 1539 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2019 | 24282 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2020 | 1144 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 14071 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 2627 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 705 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 59889 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 15880 | 0.030 |
Why?
|
| Pedigree | 1 | 2021 | 4526 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 664 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 1303 | 0.030 |
Why?
|
| Incidence | 2 | 2023 | 21480 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2002 | 2573 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2002 | 3404 | 0.020 |
Why?
|
| United States | 4 | 2023 | 72903 | 0.020 |
Why?
|
| Research | 1 | 2020 | 1975 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2016 | 872 | 0.020 |
Why?
|
| Cell Movement | 1 | 2022 | 5194 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 30198 | 0.020 |
Why?
|
| Europe | 1 | 2016 | 3423 | 0.020 |
Why?
|
| Stem Cells | 1 | 2002 | 3540 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 11022 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2014 | 2601 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 2794 | 0.020 |
Why?
|
| Research Design | 1 | 2023 | 6209 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 14751 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10563 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12795 | 0.020 |
Why?
|
| Adult | 1 | 2019 | 223044 | 0.010 |
Why?
|
| Lung Transplantation | 1 | 2014 | 1311 | 0.010 |
Why?
|
| Mice | 2 | 2021 | 81819 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 3685 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3432 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4772 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12976 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 41649 | 0.010 |
Why?
|
| Animals | 2 | 2021 | 168764 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2022 | 23601 | 0.010 |
Why?
|
| Prognosis | 1 | 2019 | 29922 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2023 | 54802 | 0.010 |
Why?
|